Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
3.565
+0.183 (5.41%)
May 5, 2025, 4:00 PM EDT - Market closed
Inventiva Employees
As of December 31, 2024, Inventiva had 118 total employees, including 114 full-time and 4 part-time employees. The number of employees decreased by 5 or -4.07% compared to the previous year.
Employees
118
Change (1Y)
-5
Growth (1Y)
-4.07%
Revenue / Employee
$123,657
Profits / Employee
-$1,616,232
Market Cap
345.72M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
IVA News
- 1 day ago - Inventiva secures the €116 million second tranche of its structured financing of up to €348 million - GlobeNewsWire
- 5 days ago - Combined General Meeting of May 22, 2025 - Availability of the preparatory documents - GlobeNewsWire
- 11 days ago - Inventiva announces the publication in Clinical Gastroenterology and Hepatology of its analysis of new biomarker signatures predictive of histological response in patients with MASH treated with lanifibranor - GlobeNewsWire
- 20 days ago - Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F - GlobeNewsWire
- 4 weeks ago - Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis - GlobeNewsWire
- 5 weeks ago - Inventiva S.A. (IVA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Inventiva reports its 2024 full year results and provides a business update - GlobeNewsWire
- 6 weeks ago - Inventiva announces the schedule of publication and presentation of its 2024 Full-Year Financial Results - GlobeNewsWire